Advertisement
Patients with long-QT syndrome treated with attention deficit/hyperactivity disorder medications have an increased risk for cardiac events

ADHD Meds Up Cardiac Event Risk in Long-QT Syndrome

0
Male patients in particular have an increased risk of cardiac events
For patients with mild-to-moderate asthma

House Dust Mite Allergen Immunotherapy Deemed Safe

0
Findings among adults with mild-to-moderate asthma; no treatment-related serious adverse events
For patients with active rheumatoid arthritis and vitamin D deficiency

Vitamin D Supplementation Beneficial in Rheumatoid Arthritis

0
Improvement in disease activity for patients with vitamin D deficiency at baseline
Direct-acting antiviral therapies are associated with high sustained virologic response rates in hepatitis C virus-associated mixed cryoglobulinemia syndrome

Direct-Acting Antiviral Therapies Beneficial in HCV-MCS

0
High sustained virologic response at 12 weeks in hep C virus-linked mixed cryoglobulinemia syndrome
New research suggests that doctors don't warn younger women when they're at risk for cardiovascular disease as often as they warn men. And once younger women suffer an ST-segment elevation myocardial infarction

Gender Gap Appears to Continue in Cardiovascular Care

0
Younger women less likely than men to be warned of risk, get same treatments or survive after MI
For patients with hepatocellular carcinoma after radiofrequency ablation

Sartans Improve Survival, Time to Recurrence in Liver Cancer

0
Sartans up outcomes in patients with hepatocellular carcinoma after radiofrequency ablation
For pregnant women with gestational diabetes mellitus or type 2 diabetes

Cellphone System Ups Glucose Self-Monitoring in Pregnancy

0
For pregnant women, improvement in compliance and satisfaction with use of CIT system

JAK Inhibitors May Help Treat Hair Loss

0
Early experimental study shows promise; more research needed
Viekira Pak and Technivie appear linked to serious liver damage in patients with advanced liver disease

FDA Requires New Warning on Two Hepatitis C Drugs

0
Cautionary label will be added to Viekira Pak and Technivie, agency says
Serogroup B meningococcal vaccination is recommended for adolescents and young adults aged 16 to 23 years to provide short-term protection from most strains of serogroup B meningococcal disease

MenB Vaccine Recommended for 16- to 23-Year-Olds

0
Preferred age for serogroup B meningococcal vaccination is 16 to 18 years